Arizona Endocrinology Center Plc

CLIA Laboratory Citation Details

3
Total Citations
14
Total Deficiencyies
14
Unique D-Tags
CMS Certification Number 03D0942072
Address 15640 N 28th Dr, Phoenix, AZ, 85053
City Phoenix
State AZ
Zip Code85053
Phone602 439-9000
Lab DirectorMAJA DAVIDSON

Citation History (3 surveys)

Survey - June 25, 2025

Survey Type: Standard

Survey Event ID: LZNH11

Deficiency Tags: D5781 D5437

Summary:

Summary Statement of Deficiencies D5437 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(a) (a )Unless otherwise specified in this subpart, for each applicable test system the laboratory must perform and document calibration procedures-- (a)(1) Following the manufacturer's test system instructions, using calibration materials provided or specified, and with at least the frequency recommended by the manufacturer; (a)(2) Using the criteria verified or established by the laboratory as specified in 493.1253(b) (3)-- (a)(2)(i) Using calibration materials appropriate for the test system and, if possible, traceable to a reference method or reference material of known value; and (a) (2)(ii) Including the number, type, and concentration of calibration materials, as well as acceptable limits for and the frequency of calibration; and (a)(3) Whenever calibration verification fails to meet the laboratory's acceptable limits for calibration verification. This STANDARD is not met as evidenced by: Based on lack of calibration records from December 2024 for Thyroid-stimulating Hormone (TSH) testing and interview with the Testing Personnel (TP-1), the laboratory failed to perform and document calibration procedures with at least the frequency recommended by the manufacturer. Findings include: 1. The laboratory utilizes the Beckman Coulter DxC 600 analyzer to perform patient testing in the subspecialty of Endocrinology, with an approximate annual test volume of 39,354. 2. The instrument manufacturer requires a calibration for TSH every 28 days. 3. The laboratory failed to provide evidence of calibration records for TSH from December 2024. 4. Calibration records reviewed for the DxC 600 analyzer for the analyte, TSH, indicated calibration procedures were performed on 11/22/24 and the next calibration was performed on 1/09/25, exceeding the 28-day requirement. 5. TP-1 interviewed on June 25, 2025 at 11:45 AM confirmed the laboratory failed to provide evidence of calibration procedures for TSH during the timeframe referenced above. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 24, 2024

Survey Type: Standard

Survey Event ID: DVJ811

Deficiency Tags: D5403 D5433 D6000 D6040 D2009 D5421 D5791 D6003 D6046

Summary:

Summary Statement of Deficiencies D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. This STANDARD is not met as evidenced by: Based on review of proficiency testing (PT) records from 2022 and 2023 and interview with testing personnel (TP-2), the laboratory director failed to sign the PT attestation statements. Findings include: 1. The laboratory performs testing in the specialties of Chemistry and Hematology with an annual test volume of 254,739. 2. The PT attestation statements presented for review for the first, second, and third testing events of 2022 and 2023 lacked the signature of the laboratory director. 3. The TP-2 interviewed on 1/24/24 at 10:40 AM confirmed the laboratory director failed to sign the PT attestation statements for the events indicated above. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - November 30, 2018

Survey Type: Standard

Survey Event ID: ITJC11

Deficiency Tags: D5291 D6029 D6053

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on review of the laboratory's established Quality Assessment (QA) policies, review of QA records and interview with the facility personnel, the laboratory failed to identify errors found with personnel competency and employee training. Findings include: 1. The laboratory performs patient testing under the specialties of Hematology, Chemistry and Diagnostic Immunology, with an approximate annual test volume of 239,038. The laboratory hired a new testing personnel in July 2017. 2. The laboratory performs a "Monthly Quality Assurance Checklist" that includes a section for Personnel. The Personnel section states, "New employees have a personnel file; Testing analyst have been checked for competency prior to reporting patient results; Semi-annual and annual evaluations have been performed; Continuing Education documentation is readily available." 3. Review of the Monthly QA Checklists from January 2017 through the date of the survey conducted on November 30, 2018 revealed that the laboratory marked a "Y(yes)"next to each area of the personnel section on each monthly form, however no documentation of initial training or semi- annual competency evaluation was presented for review during the survey for the testing personnel hired in July 2017. See D6029 and D6053 for findings. 4. The facility personnel confirmed that the laboratory's QA process was not effective in identifying errors found during the survey with regard to employee competency and training. D6029 LABORATORY DIRECTOR RESPONSIBILITIES Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- CFR(s): 493.1407(e)(11) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on lack of training documentation and interview with the facility personnel, the laboratory director failed to ensure that prior to testing patients' specimens, all personnel have the appropriate training for the type and complexity of services offered. Findings include: 1. The laboratory performs patient testing in the specialties of Diagnostic Immunology, Chemistry and Hematology, with an approximate annual test volume of 239,038 2. No initial training documentation was presented for review for one out of one testing personnel who began patient testing in July 2017. 3. The facility personnel confirmed that the testing personnel indicated above did not have documentation of initial training. . D6053 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) The technical consultant is responsible for evaluating and documenting the performance of individuals responsible for moderate complexity testing at least semiannually during the first year the individual tests patient specimens. This STANDARD is not met as evidenced by: Based on lack of performance evaluation documentation and interview with the facility personnel, the technical consultant failed to evaluate and document the performance of one testing personnel, at least semiannually during the first year the individual tested patient specimens. Findings include: 1. No semiannual competency evaluation documentation was presented for review for one testing personnel who began patient testing in July 2017. 2. The facility personnel confirmed that the laboratory did not have documentation of a semiannual competency evaluation for the testing personnel indicated above. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access